Gary Van Savage is a Senior Director of Business Development & Licensing, Immunology, Janssen Business Development.  He joined the Johnson & Johnson family of companies in 1997 as a member of the Janssen Pharmaceutica (USA) Technical Services group where he had completed the technology transfer of several new product manufacturing processes. Later, at the RW Johnson Pharmaceutical Research Institute he led the search and evaluation efforts for drug delivery technologies and secured academic research contracts.

In 2003 Gary joined the Global Pharmaceuticals Business Development Group and has since personally negotiated and executed numerous agreements encompassing research collaborations, research tools and platforms. His efforts have also helped to in-license several clinical stage Immunology assets and secure key strategic alliances.  

Before joining Johnson & Johnson, Gary worked in the New Product Development Group of SmithKline Beecham Consumer Healthcare.  He holds a B.S. (Pharmacy) and PhD (Pharmaceutical Sciences) from the University of Rhode Island and an MBA from Columbia University.